Francesco Caiazza, PhD

Title(s)Postdoctoral Scholar, Pharmaceutical Chemistry
SchoolSchool of Pharmacy
ORCID ORCID Icon0000-0003-4228-1130 Additional info
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Collaboration Interests
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Caiazza F, Oficjalska K, Tosetto M, Phelan JJ, Noonan S, Martin P, Killick K, Breen L, O'Neill F, Nolan B, Furney S, Power R, Fennelly D, Craik CS, O'Sullivan J, Sheahan K, Doherty GA, Ryan EJ. KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment. Am J Pathol. 2019 Oct; 189(10):1916-1932. PMID: 31404541.
      View in: PubMed
    2. Ivry SL, Knudsen GM, Caiazza F, Sharib JM, Jaradeh K, Ravalin M, O'Donoghue AJ, Kirkwood KS, Craik CS. The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts. Biol Chem. 2019 Jul 19. PMID: 31256057.
      View in: PubMed
    3. Hand F, Harmon C, Elliott LA, Caiazza F, Lavelle A, Maguire D, Hoti E, Nolan N, Geoghegan JG, Ryan EJ, O'Farrelly C. Depleted polymorphonuclear leukocytes in human metastatic liver reflect an altered immune microenvironment associated with recurrent metastasis. Cancer Immunol Immunother. 2018 07; 67(7):1041-1052. PMID: 29572702.
      View in: PubMed
    4. Winter MB, La Greca F, Arastu-Kapur S, Caiazza F, Cimermancic P, Buchholz TJ, Anderl JL, Ravalin M, Bohn MF, Sali A, O'Donoghue AJ, Craik CS. Immunoproteasome functions explained by divergence in cleavage specificity and regulation. Elife. 2017 11 28; 6. PMID: 29182146.
      View in: PubMed
    5. F. Hand, C. Harmon, L. Elliott, F. Caiazza, N. Nolan, J. Geoghegan, E. Ryan, C. O'Farrelly. Hepatic microenvironment: What tips the balance towards metastasis. Hepato Pancreato Biliary. 2016 Apr 1; 18:e60-e61.
      View in: Publisher Site
    6. Caiazza F, Murray A, Madden SF, Synnott NC, Ryan EJ, O'Donovan N, Crown J, Duffy MJ. Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells. Endocr Relat Cancer. 2016 Apr; 23(4):323-34. PMID: 26932782.
      View in: PubMed
    7. Caiazza F, McGowan PM, Mullooly M, Murray A, Synnott N, O'Donovan N, Flanagan L, Tape CJ, Murphy G, Crown J, Duffy MJ. Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells. Br J Cancer. 2015 Jun 09; 112(12):1895-903. PMID: 26010411; PMCID: PMC4580380.
    8. Flood B, Oficjalska K, Laukens D, Fay J, O'Grady A, Caiazza F, Heetun Z, Mills KH, Sheahan K, Ryan EJ, Doherty GA, Kay E, Creagh EM. Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential. Clin Exp Immunol. 2015 Jul; 181(1):39-50. PMID: 25943872; PMCID: PMC4469154.
    9. Caiazza F, Ryan EJ, Doherty G, Winter DC, Sheahan K. Estrogen receptors and their implications in colorectal carcinogenesis. Front Oncol. 2015; 5:19. PMID: 25699240.
      View in: PubMed
    10. Caiazza F, Elliott L, Fennelly D, Sheahan K, Doherty GA, Ryan EJ. Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies. Biomark Med. 2015; 9(4):363-75. PMID: 25808440.
      View in: PubMed
    11. Sen A, Caiazza F. Oocyte maturation: a story of arrest and release. Front Biosci (Schol Ed). 2013 Jan 01; 5:451-77. PMID: 23277062.
      View in: PubMed
    12. McGowan PM, Mullooly M, Caiazza F, Sukor S, Madden SF, Maguire AA, Pierce A, McDermott EW, Crown J, O'Donovan N, Duffy MJ. ADAM-17: a novel therapeutic target for triple negative breast cancer. Ann Oncol. 2013 Feb; 24(2):362-9. PMID: 22967992.
      View in: PubMed
    13. Caiazza F, McCarthy NS, Young L, Hill AD, Harvey BJ, Thomas W. Cytosolic phospholipase A2-a expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours. Br J Cancer. 2011 Jan 18; 104(2):338-44. PMID: 21119660; PMCID: PMC3031888.
    14. Caiazza F, Harvey BJ, Thomas W. Cytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth. Mol Endocrinol. 2010 May; 24(5):953-68. PMID: 20211985.
      View in: PubMed
    15. Thomas W, Caiazza F, Harvey BJ. Estrogen, phospholipase A and breast cancer. Front Biosci. 2008 Jan 01; 13:2604-13. PMID: 17981737.
      View in: PubMed
    16. Caiazza F, Galluzzo P, Lorenzetti S, Marino M. 17Beta-estradiol induces ERbeta up-regulation via p38/MAPK activation in colon cancer cells. Biochem Biophys Res Commun. 2007 Jul 20; 359(1):102-7. PMID: 17524358.
      View in: PubMed
    17. Galluzzo P, Caiazza F, Moreno S, Marino M. Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr Relat Cancer. 2007 Mar; 14(1):153-67. PMID: 17395984.
      View in: PubMed